Berry-Kravis E - Search Results

1

Altered steady state and activity-dependent de novo protein expression in fragile X syndrome.

Bowling H, Bhattacharya A, Zhang G, Alam D, Lebowitz JZ, Bohm-Levine N, Lin D, Singha P, Mamcarz M, Puckett R, Zhou L, Aryal S, Sharp K, Kirshenbaum K, Berry-Kravis E, Neubert TA, Klann E. Bowling H, et al. Nat Commun. 2019 Apr 12;10(1):1710. doi: 10.1038/s41467-019-09553-8. Nat Commun. 2019. PMID: 30979884 Free PMC article.

2

Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome.

Berry-Kravis E, Sklena P. Berry-Kravis E, et al. Am J Med Genet. 1993 Jan 1;45(1):81-7. doi: 10.1002/ajmg.1320450120. Am J Med Genet. 1993. PMID: 8380312

3

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.

Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L. Goldman JG, et al. Arch Neurol. 2004 Aug;61(8):1280-4. doi: 10.1001/archneur.61.8.1280. Arch Neurol. 2004. PMID: 15313848

4

Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.

Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. Berry-Kravis E, et al. Ann Neurol. 2005 Jan;57(1):144-7. doi: 10.1002/ana.20360. Ann Neurol. 2005. PMID: 15622531

5

Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.

Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, Weiler IJ, Greenough WT. Berry-Kravis E, et al. J Dev Behav Pediatr. 2008 Aug;29(4):293-302. doi: 10.1097/DBP.0b013e31817dc447. J Dev Behav Pediatr. 2008. PMID: 18698192 Clinical Trial.

6

Development of an expressive language sampling procedure in fragile X syndrome: a pilot study.

Berry-Kravis E, Doll E, Sterling A, Kover ST, Schroeder SM, Mathur S, Abbeduto L. Berry-Kravis E, et al. J Dev Behav Pediatr. 2013 May;34(4):245-51. doi: 10.1097/DBP.0b013e31828742fc. J Dev Behav Pediatr. 2013. PMID: 23669871 Free PMC article.

7

Outcome measures for clinical trials in fragile X syndrome.

Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK; Outcome Measures Working Groups. Berry-Kravis E, et al. J Dev Behav Pediatr. 2013 Sep;34(7):508-22. doi: 10.1097/DBP.0b013e31829d1f20. J Dev Behav Pediatr. 2013. PMID: 24042082 Free PMC article.

8

Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.

Berry-Kravis E. Berry-Kravis E. Pediatr Neurol. 2014 Apr;50(4):297-302. doi: 10.1016/j.pediatrneurol.2013.12.001. Epub 2013 Dec 4. Pediatr Neurol. 2014. PMID: 24518745 Review.

9

Autism and fragile X syndrome.

Yu TW, Berry-Kravis E. Yu TW, et al. Semin Neurol. 2014 Jul;34(3):258-65. doi: 10.1055/s-0034-1386764. Epub 2014 Sep 5. Semin Neurol. 2014. PMID: 25192504 Review.

10

Cholesterol levels in fragile X syndrome.

Berry-Kravis E, Levin R, Shah H, Mathur S, Darnell JC, Ouyang B. Berry-Kravis E, et al. Am J Med Genet A. 2015 Feb;167A(2):379-84. doi: 10.1002/ajmg.a.36850. Epub 2014 Nov 25. Am J Med Genet A. 2015. PMID: 25424470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page